Cardene is a brand name for nicardipine hydrochloride, a calcium channel blocker used to treat high blood pressure [1].
What other forms of nicardipine are available?
Nicardipine hydrochloride is available in several dosage forms, including capsules, injections, and solutions [1].
How does nicardipine work to lower blood pressure?
Nicardipine hydrochloride is a dihydropyridine calcium channel blocker. It works by relaxing and widening blood vessels, which reduces the resistance blood encounters as it flows through the body. This leads to a decrease in blood pressure [1].
When does the patent for nicardipine expire?
Information regarding specific patent expiration dates for nicardipine is available on DrugPatentWatch.com [2]. Patent expiry dates are crucial for determining when generic versions of a medication can enter the market.
Who manufactures nicardipine?
Various pharmaceutical companies manufacture nicardipine hydrochloride. For example, Teva Pharmaceuticals USA, Inc. has marketed nicardipine hydrochloride capsules [3].
What are the common side effects of nicardipine?
Common side effects associated with nicardipine can include headache, dizziness, flushing, nausea, and swelling in the ankles or feet [1].
What is the difference between Cardene and other blood pressure medications?
Cardene (nicardipine hydrochloride) is a calcium channel blocker. Other classes of blood pressure medications include ACE inhibitors, beta-blockers, and diuretics, each working through different mechanisms to manage hypertension. The choice of medication depends on individual patient factors and medical history.
Can I switch from Cardene to a generic version?
Patients considering switching from a brand-name drug like Cardene to a generic equivalent should consult their healthcare provider. Generic medications contain the same active ingredient and are approved by regulatory agencies to be as safe and effective as their brand-name counterparts.
---
Sources:
[1] https://www.webmd.com/drugs/2/drug-6804/cardene-oral/details
[2] https://www.drugpatentwatch.com/
[3] https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050669s031,050706s019,050715s018lbl.pdf